Clinical Trial to Evaluate the Safety and Efficacy of Scalp Med in Treatment of Patients with Androgenetic Alopecia

    January 2008 in “ Journal of Clinical Dermatology
    Bark-Lynn Lew, Woo-Young Sim, Chang Hun Huh, Jang-Kyu Park
    TLDR Scalp medⓇ effectively and safely improves hair growth in men with androgenetic alopecia.
    The clinical trial evaluated the safety and efficacy of Scalp medⓇ, a topical solution containing minoxidil, retinol, polysorbate 80, and phytosterol, in treating androgenetic alopecia (AGA) in males aged 20 to 60 with mild to moderate AGA. Over 24 weeks, the study demonstrated significant improvements in hair count and thickness in all participants, establishing Scalp medⓇ as an effective and safe treatment for AGA.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    20 / 20 results